Mirabegron a Tool Against Obesity? Pilot Study on Bladder Drug

January 7, 2015 3:39 PM

15 0

A drug already on the market for treating overactive bladder is showing promise in helping patients lose weight and fight obesity. Before you start peppering your primary doctor with requests for mirabegron (commercial name – Mybertiq), there are some caveats.

The study showing promise was a 12-man pilot study. In it, researchers gave the 12 male volunteers four-times the recommended dose of Mybertiq. The drug targets the β3-adrenergic receptor. This receptor expresses not only in in the bladder, but also fat cells. Enter the scientists that wanted to see...

Read more

To category page